Secondary Prevention Treatment in patients who have suffered a cardiovascular event

Study identifier:NIS-CZA-XXX-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Secondary Prevention Treatment in patients who have suffered a cardiovascular event.

Medical condition

Cardiovascular Events

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

88

Study type

Observational

Age

None - None

Date

Study Start Date: 01 Jan 2010
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2011 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria